期刊文献+

对急性加重期慢性阻塞性肺疾病住院患者实施药学服务的效果探析 被引量:3

Effect pharmaceutical care for the patients with acute exacerbations of COPD
下载PDF
导出
摘要 目的 :分析对急性加重期慢性阻塞性肺疾病(简称慢阻肺)住院患者实施药学服务的临床效果。方法 :选取2016年2月至2017年3月期间在富顺县人民医院住院治疗的60例急性加重期慢阻肺患者作为研究对象。随机将这些患者平均分为药学组(n=30)和比照组(n=30)。在这两组患者住院治疗期间,均对其进行常规治疗。在此基础上,对药学组患者进行药学服务,不对比照组患者进行药学服务。然后,比较两组患者的各项临床指标以及头痛、过敏、呕吐、恶心等不良反应的发生情况。结果 :接受药学服务后,与比照组患者相比,药学组患者的白细胞计数、红细胞沉降率、P02(氧分压)的水平以及头痛、过敏、呕吐、恶心等用药不良反应的发生率均明显更低,其PC02(二氧化碳分压)的水平明显更高,差异具有统计学意义(P<0.05)。结论 :对急性加重期慢阻肺住院患者实施药学服务的效果显著,可有效地改善其各项临床指标,降低其用药不良反应的发生率,从而确保其用药的有效性与安全性。 objective: to analyze the clinical effect of drug delivery in patients with acute exacerbation of chronic obstructive pulmonary disease(copd). Methods: 60 patients with acute exacerbation of chronic obstructive pulmonary disease were selected from February 2016 to March 2017 at fushun county people's hospital. These patients were randomly divided into the pharmaceutical group(n=30) and the comparison group(n=30). Both groups were treated with routine treatment during hospitalization. On this basis, pharmacological services were performed for patients in the pharmaceutical group, and no pharmaceutical services were performed in the group. Then, we compared the clinical indicators of the two groups and the incidence of headache, allergy, vomiting, nausea and other adverse reactions. Results: after accepting pharmaceutical care, compared with a comparison group of patients, pharmaceutical group of the patient's white blood count and erythrocyte sedimentation rate, P〈02(oxygen partial pressure) levels as well as headaches, allergies, vomiting, nausea, etc. The incidence of drug adverse reactions were significantly lower, its PC02(co_2 partial pressure) level is significantly higher, statistically significant difference(P〈0.05). Conclusion: for patients with acute aggravating period of copd in hospital implementation of pharmaceutical care effect significantly, can effectively improve the clinical indicators, reduce the incidence of drug adverse reactions, thus to ensure the effectiveness of its application and security.
作者 刘娟 Lin Juan(fushun county people' s hospital, sichuan zigong 64300)
机构地区 富顺县人民医院
出处 《当代医药论丛》 2018年第7期14-16,共3页
关键词 慢性阻塞性肺疾病 药学服务 不良反应 血常规 红细胞沉降率 chronic obstructive pulmonary disease Pharmaceutical services Adverse reactions Routine blood Erythrocyte sedimentation rate
  • 相关文献

参考文献6

二级参考文献62

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 2王蕾,戴路明.糖皮质激素在慢性阻塞性肺疾病治疗中的应用[J].国际呼吸杂志,2007,27(3):236-238. 被引量:7
  • 3GOLD executive committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (revised 2011)[EB/OL]. (2011-12)[2012-05]. http:// www.goldcopd.org.
  • 4EMEA. Short-acting beta agonists (SABAs)- risk of myocardial ischaemia [EB/OL]. (2009-10-29)[2012-05]. http://www.ema. europa.eu/pdfs/human/phvwp/66624309en.pdf.
  • 5WANG R H,WANG H,CHEN X.Investigation of the pharmacy services necessity for pregnant and puerperalwomen[J].中国医院药学杂志,2008,28(17):1508-1509.
  • 6THE ASTHMA DISEASE GROUP OF THE RESPIRATORY DISEASE CHAPTER IN CHINESE MEDICAL ASSOCIATION.Diagnosis and treatment guide of chronic obstructive pulmonary disease [J].中华结核和呼吸系疾病杂志,2013,36(5):331-336.
  • 7THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE GROUP OF THE RESPIRATORY DISEASE CHAPTER 1N CHINESE MEDICAL ASSOCIATION.Diagnosis and treatment guide of chronic obstructive pulmonary disease [J].中华结核和呼吸系疾病杂志,2013,36(4):1-10.
  • 8Y1N K S.Practical Pharmacology of Antiinfective Agents(实用抗感染药物治疗学)[M].2nd Ed.Beijing:People'sMedical Publishing House,2011:104.
  • 9DAI Z Y.The basic principles of medication in pregnantpatients[J].实用妇产科杂志,2007,23(10):581-582.
  • 10DAO H,GAO Y B.The clinical analysis of using hormones for bronchial asthma during pregnancy [J].临床肺科杂志,2013,18(3):543.

共引文献27

同被引文献17

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部